Press release
Carbapenemase Producing Assay Kit Market to Reach USD 432.7 Million by 2034
Carbapenemase Producing Assay Kit Market
Carbapenemase producing assay kits are in-vitro diagnostic tools used to detect enzymes that confer resistance to carbapenem antibiotics-one of the last lines of defense in treating multidrug-resistant bacterial infections. These kits are vital in screening clinical isolates, guiding antibiotic stewardship programs, and preventing the spread of carbapenem-resistant Enterobacteriaceae (CRE) and other gram-negative pathogens.
With WHO listing antimicrobial resistance among the top 10 global public health threats, diagnostic innovations like these assay kits are gaining prominence in hospital labs, surveillance programs, and research settings.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/reports/58917/global-carbapenemase-producing-assay-kit-market#request-a-sample
Key Highlights:
• Market Size (2024): USD 213.4 Million
• Forecast (2034): USD 432.7 Million
• CAGR (2024-2034): 7.3%
• Key Drivers: Rising AMR burden, global hospital infection control, increased diagnostic testing
• Challenges: Cost in low-resource regions, regulatory approvals, sensitivity limitations
• Top Players: Roche Diagnostics, BD Biosciences, Thermo Fisher Scientific, bioMérieux, Liofilchem, Creative Diagnostics, Norgen Biotek, Qiagen, ELITechGroup, ZeptoMetrix
Segmentation Analysis
By Type:
• Colorimetric Assay Kits
• PCR-Based Assay Kits
• Lateral Flow Assays
• ELISA-Based Kits
By Target Enzyme:
• KPC (Klebsiella pneumoniae carbapenemase)
• NDM (New Delhi metallo-β-lactamase)
• OXA-48
• VIM & IMP
• Multi-Class Detection Kits
By Sample Type:
• Blood Samples
• Urine Samples
• Rectal Swabs
• Respiratory Samples
• Other Clinical Specimens
By End-Use:
• Hospital Microbiology Labs
• Diagnostic Centers
• Academic & Research Institutions
• Public Health Laboratories
• Pharmaceutical & CROs
Summary:
PCR-based and lateral flow assays are dominating the market due to their rapid turnaround and high sensitivity in detecting multiple carbapenemase genes. KPC and NDM detection kits are most in demand, especially in high-risk regions. Usage is highest in hospital microbiology labs, which serve as the front line for AMR containment.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/58917/global-carbapenemase-producing-assay-kit-market
Regional Analysis
North America:
• Dominates global market due to the CDC's active CRE surveillance programs and widespread diagnostic lab infrastructure.
• U.S. leads in innovation, rapid adoption of molecular diagnostics, and antibiotic stewardship initiatives.
Europe:
• Strong demand in Germany, UK, France, and Italy due to EUCAST guidelines, ECDC-supported AMR surveillance, and universal healthcare access.
• Laboratories increasingly adopting multiplex detection kits for hospital-based screening.
Asia-Pacific:
• Fastest-growing region driven by increasing CRE prevalence in India, China, and Southeast Asia.
• Governments and international organizations are ramping up funding for rapid AMR diagnostics and infection control.
Middle East & Africa:
• Gradual uptake in UAE, Saudi Arabia, and South Africa as part of healthcare modernization and WHO AMR stewardship campaigns.
Latin America:
• Brazil and Mexico witness rising demand as hospital-acquired infection surveillance strengthens through regional partnerships.
Summary:
North America and Europe dominate in revenue and testing volume, but Asia-Pacific is projected to post the highest CAGR through 2034 due to widespread AMR prevalence and improved access to diagnostics.
Market Dynamics
Growth Drivers:
1. Global Burden of Antimicrobial Resistance:
Rising cases of CRE, Acinetobacter, and Pseudomonas infections are pushing healthcare systems to deploy fast and accurate carbapenemase detection kits.
2. Policy-Driven AMR Surveillance Programs:
Governments and global health agencies are integrating assay kits into national action plans for AMR containment and outbreak response.
3. Hospital Infection Control Protocols:
Hospitals are routinely screening patients for colonization to prevent CRE outbreaks in ICUs, transplant wards, and long-term care units.
4. Advances in Diagnostic Sensitivity and Multiplexing:
Newer kits can detect multiple carbapenemase genes simultaneously, improving efficiency and supporting targeted treatment strategies.
Challenges:
• High Cost of PCR and ELISA-Based Kits:
Advanced molecular kits may not be affordable in resource-limited settings, limiting testing coverage.
• False Negatives and Genetic Mutation Risks:
Carbapenemase genes can evolve, sometimes evading detection by standard assays.
• Regulatory Barriers and Standardization Needs:
Market access is challenged by strict validation requirements, especially in the U.S. (FDA) and Europe (IVDR).
Trends:
• Rise of Point-of-Care and Rapid Testing Kits:
Lateral flow and colorimetric kits are enabling bedside testing in ERs and field hospitals.
• Automation and AI Integration in Labs:
Some labs are pairing assay kits with AI-driven interpretation tools for faster reporting and clinical decision-making.
• Cloud-Based Reporting and AMR Dashboards:
Public health authorities are using diagnostic kit data for real-time resistance mapping and trend analysis.
• Collaborative Product Development:
Partnerships between diagnostic firms, hospitals, and public health bodies are driving the development of localized resistance detection kits.
Get Your Exclusive Offer with up to 10% Discount:
https://exactitudeconsultancy.com/purchase/?currency=USD&type=single_user_license&report_id=58917
Competitor Analysis
Major Players:
• Roche Diagnostics: Offers PCR-based kits and real-time PCR platforms integrated with hospital information systems.
• BD Biosciences: Known for the Phoenix and BD MAX platforms, enabling automated detection and workflow integration.
• Thermo Fisher Scientific: Supplies multiplexed AMR detection panels and customized laboratory solutions.
• bioMérieux: Provides chromogenic and molecular detection kits under the BioFire and Etest brands.
• Liofilchem (Italy): Offers the MIC Test Strip for carbapenemase phenotypic confirmation.
• Creative Diagnostics: U.S.-based supplier of ELISA kits and custom assay development.
• Qiagen: Known for its QIAstat-Dx and GeneReader platforms targeting hospital-acquired resistance pathogens.
• Norgen Biotek (Canada): Supplies DNA-based assays for clinical labs and surveillance programs.
• ELITechGroup (France): Offers real-time PCR kits for infectious disease testing including AMR profiling.
• ZeptoMetrix (US): Provides AMR controls and reference materials alongside diagnostic kit development.
Competitive Summary:
The market features a mix of global diagnostic giants and specialty molecular assay developers. Players are competing on turnaround time, accuracy, panel coverage (KPC, NDM, OXA-48, VIM, IMP), automation compatibility, and regional customization. Collaborations with governments, WHO, and hospital chains are shaping market outreach and regulatory alignment.
Conclusion: Frontline Diagnostic Tools in the Global AMR Battle
As antimicrobial resistance becomes a defining global health crisis, carbapenemase producing assay kits are indispensable tools for early detection, targeted treatment, and epidemic prevention. Hospitals, diagnostic centers, and national health systems are embracing these kits to improve patient safety and reduce healthcare-associated infection risks.
This report is also available in the following languages : Japanese (カルバペネマーゼ産生アッセイキット), Korean (카바페넴 분해효소 생성 분석 키트), Chinese (碳青霉烯酶检测试剂盒), French (Kit de dosage de production de carbapénémase), German (Carbapenemase-produzierendes Testkit), and Italian (Kit di analisi per la produzione di carbapenemasi), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/reports/58917/global-carbapenemase-producing-assay-kit-market#request-a-sample
Our More Report:
Bain Maries and Cabinets
https://exactitudeconsultancy.com/reports/63878/global-bain-maries-and-cabinets-market
Occupancy Sensor
https://exactitudeconsultancy.com/reports/63880/global-occupancy-sensor-market
Imaging Flow Cytometry
https://exactitudeconsultancy.com/reports/63882/global-imaging-flow-cytometry-market
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Carbapenemase Producing Assay Kit Market to Reach USD 432.7 Million by 2034 here
News-ID: 4117570 • Views: …
More Releases from Exactitiude Consultancy
Non-Muscle Invasive Bladder Cancer Market Industry Analysis by Size, Share, Grow …
Introduction
The Non-Muscle Invasive Bladder Cancer (NMIBC) market is poised for significant growth as advancements in intravesical therapies, immuno-oncology drugs, and molecular diagnostics improve patient outcomes. NMIBC, which accounts for about 70-75% of all newly diagnosed bladder cancer cases, is characterized by high recurrence rates but relatively low mortality compared to muscle-invasive forms. The rising global prevalence, particularly among aging populations, is prompting greater investment in early diagnosis, novel drug delivery…
NK Cell Therapy Market Size And Global Industry Forecast 2034
NK Cell Therapy Market Outlook 2024-2034: Immuno-Oncology Innovation and Off-the-Shelf Therapies Set the Stage for Rapid Growth
Introduction
The Natural Killer (NK) Cell Therapy market is one of the most dynamic segments in immuno-oncology, driven by breakthroughs in cell engineering, off-the-shelf allogeneic therapies, and combination regimens with checkpoint inhibitors. NK cells, part of the innate immune system, have demonstrated strong potential in targeting and destroying cancer cells without prior sensitization, making them…
Neuroendocrine Prostate Cancer Market Size, Share and Growth Report, 2034
Introduction
The Neuroendocrine Prostate Cancer (NEPC) market is emerging as a key focus area in oncology due to its aggressive nature, poor prognosis, and increasing recognition as a distinct clinical entity. NEPC can develop de novo or as a treatment-emergent form of advanced prostate cancer following androgen deprivation therapy (ADT) resistance. While rare, NEPC is challenging to treat, requiring a combination of chemotherapy, targeted agents, and investigational therapies. Rising awareness, advancements…
Metastatic Colorectal Cancer Market Size And Global Industry Forecast 2034
Introduction
The Metastatic Colorectal Cancer (mCRC) market is entering a transformative phase as precision medicine, biomarker-driven treatment strategies, and immunotherapy reshape patient care. Increasing adoption of EGFR inhibitors, VEGF inhibitors, immune checkpoint inhibitors, and combination regimens is improving survival rates, while advancements in molecular diagnostics are enabling more tailored treatment approaches. Over the next decade, continuous R&D efforts and expanded access to innovative therapies are expected to drive market growth.
Download Full…
More Releases for AMR
The 73rd AMR China International Auto Parts Exhibition
Exhibition Introduction
With the further recovery of the economy, consumer confidence has been boosted and gradually restored. China's automobile industry has shown strong resilience in the ever-changing market environment and ushered in an important period of opportunity for transformation, upgrading and high-quality development.
As a highly influential automotive aftermarket industry event in northern China, especially in the Beijing-Tianjin-Hebei region, the AMR China International Automotive Maintenance, Inspection and Diagnosis Equipment, Parts and Beauty…
Yeast Ingredients Market Booming $6.6Bn by 2032 | AMR
According to a new report published by Allied Market Research, titled, "Yeast Ingredients Market," The yeast ingredients market was valued at $2.9 billion in 2022, and is estimated to reach $6.6 billion by 2032, growing at a CAGR of 8.8% from 2023 to 2032.
𝐀𝐜𝐜𝐞𝐬𝐬 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://www.alliedmarketresearch.com/request-sample/A323211
Yeast ingredients find extensive applications across diverse sectors including food & beverage, pharmaceuticals, and animal feed owing to their multifaceted properties. Despite…
Sustainability LIVE Dubai: Amr Kandil, Schneider Electric
Amr Kandil, MEA Director of Real Estate segment and New Energy Landscape at Schneider Electric to speak at Sustainability LIVE Dubai - 15 May 2024
Connecting the world's sustainability leaders, Sustainability LIVE will be returning in 2024 to bring the biggest global businesses together to deliver insightful keynotes, fireside chats, and panel discussions sharing valuable knowledge and real-world experiences.
The ultimate virtual event for sustainability and ESG leaders in the Middle East…
AGV & AMR in Logistics Market Automated Guided Vehicles (AGV) and Autonomous Mob …
The Report on "AGV & AMR in Logistics Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making.
Market Growth of AGV & AMR in Logistics Market: The AGV & AMR in Logistics market is experiencing robust growth driven by the increasing need for automated and efficient material handling in logistics and warehousing. Market…
The Growing Importance of the Cephalosporin Market | By AMR
Allied Market Research recently said Cephalosporins are a group of antibiotics that have been widely used in the medical industry for over 50 years. They were first discovered in 1945 by Dr. Giuseppe Brotzu, an Italian scientist, and were initially used to treat staphylococcal infections. Today, cephalosporins are used to treat a wide range of bacterial infections and are considered one of the most important classes of antibiotics.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞…
UGV Adoptions boost Global Autonomous Mobile Robots (AMR) Market
Inkwood Research expects the Global Autonomous Mobile Robots (AMR) Market to surge with a 21.31% CAGR during the forecast years between 2022 and 2030, generating $14473.73 million in revenue by 2030.
Browse 45 market Data Tables and 43 Figures spread over 224 Pages, along with an in-depth analysis of the Global Autonomous Mobile Robots (AMR) Market by Robot Type, End-User, & Geography.
This insightful market research report by Inkwood Research focuses on…
